Ignite Creation Date:
2024-05-06 @ 2:36 PM
Last Modification Date:
2024-10-26 @ 1:34 PM
Study NCT ID:
NCT04368507
Status:
COMPLETED
Last Update Posted:
2022-11-14
First Post:
2019-11-24
Brief Title:
To Evaluate the Safety Tolerability Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan Patients Who Are Metastatic or Recurrent Colorectal Cancer Patients
Sponsor:
Organization:
CellabMED
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
35
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE1 |
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: